RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
53 hedge funds and large institutions have $7.91M invested in Repros Therapeutics Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
65% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 20
Holders
53
Holding in Top 10
–
Calls
$207K
Puts
$72K
Top Buyers
| 1 | +$314K | |
| 2 | +$287K | |
| 3 | +$139K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$27K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$17K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$316K | |
| 3 | -$220K | |
| 4 |
RA
Royce & Associates
New York
|
-$156K |
| 5 |
Goldman Sachs
New York
|
-$110K |